Physician Assistant · Bronx, NY
NPI
1508839267
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
85 W Burnside Ave
Bronx, NY, 10453
Phone (718) 716-4400
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,273
48 services
Medicare patients, 2024
14
Average age 64
Drug cost, 2024
$4.6M
12,910 prescriptions
Company payments, 2025
$39K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julius Nwosu was code 99213 (office e&m - established), 40 times for 14 patients. In total Julius Nwosu billed 48 services in 4 codes, and Medicare paid $3,273.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-08-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 40 | 14 | $63.56 | $2,542 |
Medicare prescription drug claims, 2024
In 2024, the drug Julius Nwosu prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 916 prescriptions and refills. In total Julius Nwosu wrote 12,910 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 916 | 916 | 199 | $16K |
| Omeprazole Generic | 522 | 682 | 99 | $3,839 |
| Atorvastatin Calcium Generic | 515 | 955 | 124 | $4,801 |
| Losartan Potassium Generic | 350 | 687 | 90 | $2,602 |
| Gabapentin Generic | 336 | 373 | 83 | $2,433 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 327 | 414 | 69 | $14K |
| Simvastatin Generic | 324 | 690 | 70 | $1,894 |
| Amlodipine Besylate Generic | 287 | 624 | 78 | $1,765 |
| Endocet Oxycodone Hcl/Acetaminophen | 282 | 282 | 67 | $6,238 |
| Meloxicam Generic | 277 | 311 | 63 | $1,297 |
| Diclofenac Sodium Generic | 264 | 273 | 84 | $90K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 249 | 263 | 37 | $988K |
| Lisinopril Generic | 241 | 490 | 58 | $1,316 |
| Relistor Methylnaltrexone Bromide | 228 | 228 | 66 | $521K |
| Ozempic Semaglutide | 222 | 254 | 33 | $235K |
Brand drugs: 3,350 claims; generic drugs: 9,196 claims; opioid claims: 1,355.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julius Nwosu $39K ($39K in general payments such as food, travel and fees) from 21 companies. The largest payer was Gilead Sciences, Inc. with $27K.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 78 | $27K |
| ViiV Healthcare Company GSK | 66 | $7,168 |
| Abbvie Inc. ABBV | 15 | $1,956 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 34 | $491 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $420 |
| Ardelyx, Inc. ARDX | 19 | $366 |
| Novo Nordisk Inc NVO | 7 | $282 |
| Astellas Pharma US Inc 4503.T | 8 | $239 |
| Scilex Pharmaceuticals Inc. | 19 | $168 |
| Merck Sharp & Dohme LLC MRK | 6 | $153 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.